Global Type 1 diabetes market is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in ...

Companies like Pfizer, Amgen, AbbVie, Novartis, and others are advancing Opioid Use Disorder treatments, focusing on improving symptoms and patient ...

Pfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated ...

Novo Nordisk will take control of three fill-finish facilities of the contract drug manufacturer in Italy, Belgium ... including Eli Lilly (LLY.N), opens new tab, which makes the rival drug ...

Eli Lilly LLY announced results from the phase III ... The drug is marketed by Italy-based Menarini Group. AstraZeneca AZN is also developing its oral SERD drug, camizestrant, in multiple late ...

Novo Holdings, the controlling shareholder of Novo Nordisk, on Wednesday sealed its $16.5 billion deal for Catalent, as the ...

Differences in how men and women manifest and experience psoriatic arthritis suggest it’s time to think of patient sex as a ...

Eli Lilly has acquired Prevail ... Japan, UK, Germany, France, Italy, or Spain. Lilly pointed out that there can be no assurance of payouts from the CVR – something that shareholders in other ...

The outcome means the case could be tried again in the future - something Arm vowed to pursue in a statement following the ...

JAMA: Italy's mortality rate is three times higher than China's, and the official reason is revealed With many companies entering the anesthetic market, who will be the dominant player? Eli Lilly to t ...

During the conference, the delegation joined representatives of Eli Lilly & Company ... were exchanged between the two regions in 2023. In Italy, the delegation met with senior officials of ...

Devauchelle, JE Gottenberg and A Saraux and patient representative Maggy Pincemin (France); Dr T Dörner (Germany); Dr A Tzoufias (Greece); Drs C Baldini, S Bombardieri and S De Vita (Italy); Drs K ...